Global Human Plasma Protein Products Supply, Demand and Key Producers, 2023-2029
The global Human Plasma Protein Products market size is expected to reach $ 51020 million by 2029, rising at a market growth of 7.3% CAGR during the forecast period (2023-2029).
The Human Plasma Fractionation Product Market is driven by the increasing demand for plasma-derived therapies and the rising prevalence of various diseases. These products, including clotting factors and immunoglobulins, are crucial for treating rare and life-threatening conditions. However, a significant challenge is the need for a stable supply of plasma donations and the complex fractionation processes required to manufacture these products. Ensuring the safety and quality of plasma-derived therapies through strict regulatory compliance is another challenge for manufacturers. Additionally, market competition and pricing pressures pose challenges, necessitating a balance between affordability and sustaining the supply chain to meet the healthcare demands while maintaining the highest standards of patient care.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
This report studies the global Human Plasma Protein Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Plasma Protein Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Plasma Protein Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Plasma Protein Products total market, 2018-2029, (USD Million)
Global Human Plasma Protein Products total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Plasma Protein Products total market, key domestic companies and share, (USD Million)
Global Human Plasma Protein Products revenue by player and market share 2018-2023, (USD Million)
Global Human Plasma Protein Products total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Plasma Protein Products total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Human Plasma Protein Products market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Plasma Protein Products market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Plasma Protein Products Market, By Region:
1. How big is the global Human Plasma Protein Products market?
2. What is the demand of the global Human Plasma Protein Products market?
3. What is the year over year growth of the global Human Plasma Protein Products market?
4. What is the total value of the global Human Plasma Protein Products market?
5. Who are the major players in the global Human Plasma Protein Products market?
The Human Plasma Fractionation Product Market is driven by the increasing demand for plasma-derived therapies and the rising prevalence of various diseases. These products, including clotting factors and immunoglobulins, are crucial for treating rare and life-threatening conditions. However, a significant challenge is the need for a stable supply of plasma donations and the complex fractionation processes required to manufacture these products. Ensuring the safety and quality of plasma-derived therapies through strict regulatory compliance is another challenge for manufacturers. Additionally, market competition and pricing pressures pose challenges, necessitating a balance between affordability and sustaining the supply chain to meet the healthcare demands while maintaining the highest standards of patient care.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
This report studies the global Human Plasma Protein Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Plasma Protein Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Plasma Protein Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Plasma Protein Products total market, 2018-2029, (USD Million)
Global Human Plasma Protein Products total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Plasma Protein Products total market, key domestic companies and share, (USD Million)
Global Human Plasma Protein Products revenue by player and market share 2018-2023, (USD Million)
Global Human Plasma Protein Products total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Plasma Protein Products total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Human Plasma Protein Products market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Plasma Protein Products market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Plasma Protein Products Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
- Hospital
- Retail Pharmacy
- Other
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
1. How big is the global Human Plasma Protein Products market?
2. What is the demand of the global Human Plasma Protein Products market?
3. What is the year over year growth of the global Human Plasma Protein Products market?
4. What is the total value of the global Human Plasma Protein Products market?
5. Who are the major players in the global Human Plasma Protein Products market?
1 SUPPLY SUMMARY
1.1 Human Plasma Protein Products Introduction
1.2 World Human Plasma Protein Products Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Human Plasma Protein Products Total Market by Region (by Headquarter Location)
1.3.1 World Human Plasma Protein Products Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Human Plasma Protein Products Market Size (2018-2029)
1.3.3 China Human Plasma Protein Products Market Size (2018-2029)
1.3.4 Europe Human Plasma Protein Products Market Size (2018-2029)
1.3.5 Japan Human Plasma Protein Products Market Size (2018-2029)
1.3.6 South Korea Human Plasma Protein Products Market Size (2018-2029)
1.3.7 ASEAN Human Plasma Protein Products Market Size (2018-2029)
1.3.8 India Human Plasma Protein Products Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Plasma Protein Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Plasma Protein Products Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Plasma Protein Products Consumption Value (2018-2029)
2.2 World Human Plasma Protein Products Consumption Value by Region
2.2.1 World Human Plasma Protein Products Consumption Value by Region (2018-2023)
2.2.2 World Human Plasma Protein Products Consumption Value Forecast by Region (2024-2029)
2.3 United States Human Plasma Protein Products Consumption Value (2018-2029)
2.4 China Human Plasma Protein Products Consumption Value (2018-2029)
2.5 Europe Human Plasma Protein Products Consumption Value (2018-2029)
2.6 Japan Human Plasma Protein Products Consumption Value (2018-2029)
2.7 South Korea Human Plasma Protein Products Consumption Value (2018-2029)
2.8 ASEAN Human Plasma Protein Products Consumption Value (2018-2029)
2.9 India Human Plasma Protein Products Consumption Value (2018-2029)
3 WORLD HUMAN PLASMA PROTEIN PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Plasma Protein Products Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Plasma Protein Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Plasma Protein Products in 2022
3.2.3 Global Concentration Ratios (CR8) for Human Plasma Protein Products in 2022
3.3 Human Plasma Protein Products Company Evaluation Quadrant
3.4 Human Plasma Protein Products Market: Overall Company Footprint Analysis
3.4.1 Human Plasma Protein Products Market: Region Footprint
3.4.2 Human Plasma Protein Products Market: Company Product Type Footprint
3.4.3 Human Plasma Protein Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Plasma Protein Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Plasma Protein Products Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Human Plasma Protein Products Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Human Plasma Protein Products Consumption Value Comparison
4.2.1 United States VS China: Human Plasma Protein Products Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Plasma Protein Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Human Plasma Protein Products Companies and Market Share, 2018-2023
4.3.1 United States Based Human Plasma Protein Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Plasma Protein Products Revenue, (2018-2023)
4.4 China Based Companies Human Plasma Protein Products Revenue and Market Share, 2018-2023
4.4.1 China Based Human Plasma Protein Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Plasma Protein Products Revenue, (2018-2023)
4.5 Rest of World Based Human Plasma Protein Products Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Human Plasma Protein Products Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Plasma Protein Products Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Plasma Protein Products Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Globulin
5.2.2 Coagulation Factor
5.2.3 Albumin
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Human Plasma Protein Products Market Size by Type (2018-2023)
5.3.2 World Human Plasma Protein Products Market Size by Type (2024-2029)
5.3.3 World Human Plasma Protein Products Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Plasma Protein Products Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Human Plasma Protein Products Market Size by Application (2018-2023)
6.3.2 World Human Plasma Protein Products Market Size by Application (2024-2029)
6.3.3 World Human Plasma Protein Products Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Human Plasma Protein Products Product and Services
7.1.4 Takeda Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Human Plasma Protein Products Product and Services
7.2.4 CSL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 Grifols
7.3.1 Grifols Details
7.3.2 Grifols Major Business
7.3.3 Grifols Human Plasma Protein Products Product and Services
7.3.4 Grifols Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Grifols Recent Developments/Updates
7.3.6 Grifols Competitive Strengths & Weaknesses
7.4 Octapharma
7.4.1 Octapharma Details
7.4.2 Octapharma Major Business
7.4.3 Octapharma Human Plasma Protein Products Product and Services
7.4.4 Octapharma Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Octapharma Recent Developments/Updates
7.4.6 Octapharma Competitive Strengths & Weaknesses
7.5 Kedrion
7.5.1 Kedrion Details
7.5.2 Kedrion Major Business
7.5.3 Kedrion Human Plasma Protein Products Product and Services
7.5.4 Kedrion Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Kedrion Recent Developments/Updates
7.5.6 Kedrion Competitive Strengths & Weaknesses
7.6 LFB Group
7.6.1 LFB Group Details
7.6.2 LFB Group Major Business
7.6.3 LFB Group Human Plasma Protein Products Product and Services
7.6.4 LFB Group Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 LFB Group Recent Developments/Updates
7.6.6 LFB Group Competitive Strengths & Weaknesses
7.7 Biotest
7.7.1 Biotest Details
7.7.2 Biotest Major Business
7.7.3 Biotest Human Plasma Protein Products Product and Services
7.7.4 Biotest Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Biotest Recent Developments/Updates
7.7.6 Biotest Competitive Strengths & Weaknesses
7.8 BPL
7.8.1 BPL Details
7.8.2 BPL Major Business
7.8.3 BPL Human Plasma Protein Products Product and Services
7.8.4 BPL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 BPL Recent Developments/Updates
7.8.6 BPL Competitive Strengths & Weaknesses
7.9 RAAS
7.9.1 RAAS Details
7.9.2 RAAS Major Business
7.9.3 RAAS Human Plasma Protein Products Product and Services
7.9.4 RAAS Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 RAAS Recent Developments/Updates
7.9.6 RAAS Competitive Strengths & Weaknesses
7.10 CBPO
7.10.1 CBPO Details
7.10.2 CBPO Major Business
7.10.3 CBPO Human Plasma Protein Products Product and Services
7.10.4 CBPO Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CBPO Recent Developments/Updates
7.10.6 CBPO Competitive Strengths & Weaknesses
7.11 Hualan Bio
7.11.1 Hualan Bio Details
7.11.2 Hualan Bio Major Business
7.11.3 Hualan Bio Human Plasma Protein Products Product and Services
7.11.4 Hualan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hualan Bio Recent Developments/Updates
7.11.6 Hualan Bio Competitive Strengths & Weaknesses
7.12 Tiantan Bio
7.12.1 Tiantan Bio Details
7.12.2 Tiantan Bio Major Business
7.12.3 Tiantan Bio Human Plasma Protein Products Product and Services
7.12.4 Tiantan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Tiantan Bio Recent Developments/Updates
7.12.6 Tiantan Bio Competitive Strengths & Weaknesses
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Details
7.13.2 Shuanglin Bio Major Business
7.13.3 Shuanglin Bio Human Plasma Protein Products Product and Services
7.13.4 Shuanglin Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Shuanglin Bio Recent Developments/Updates
7.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
7.14 Boya Bio
7.14.1 Boya Bio Details
7.14.2 Boya Bio Major Business
7.14.3 Boya Bio Human Plasma Protein Products Product and Services
7.14.4 Boya Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Boya Bio Recent Developments/Updates
7.14.6 Boya Bio Competitive Strengths & Weaknesses
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Details
7.15.2 Yuanda Shuyang Major Business
7.15.3 Yuanda Shuyang Human Plasma Protein Products Product and Services
7.15.4 Yuanda Shuyang Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Yuanda Shuyang Recent Developments/Updates
7.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
7.16 Weiguang Bio
7.16.1 Weiguang Bio Details
7.16.2 Weiguang Bio Major Business
7.16.3 Weiguang Bio Human Plasma Protein Products Product and Services
7.16.4 Weiguang Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Weiguang Bio Recent Developments/Updates
7.16.6 Weiguang Bio Competitive Strengths & Weaknesses
7.17 Nanyue Bio
7.17.1 Nanyue Bio Details
7.17.2 Nanyue Bio Major Business
7.17.3 Nanyue Bio Human Plasma Protein Products Product and Services
7.17.4 Nanyue Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Nanyue Bio Recent Developments/Updates
7.17.6 Nanyue Bio Competitive Strengths & Weaknesses
7.18 KM Biologics
7.18.1 KM Biologics Details
7.18.2 KM Biologics Major Business
7.18.3 KM Biologics Human Plasma Protein Products Product and Services
7.18.4 KM Biologics Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 KM Biologics Recent Developments/Updates
7.18.6 KM Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Plasma Protein Products Industry Chain
8.2 Human Plasma Protein Products Upstream Analysis
8.3 Human Plasma Protein Products Midstream Analysis
8.4 Human Plasma Protein Products Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Plasma Protein Products Introduction
1.2 World Human Plasma Protein Products Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Human Plasma Protein Products Total Market by Region (by Headquarter Location)
1.3.1 World Human Plasma Protein Products Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Human Plasma Protein Products Market Size (2018-2029)
1.3.3 China Human Plasma Protein Products Market Size (2018-2029)
1.3.4 Europe Human Plasma Protein Products Market Size (2018-2029)
1.3.5 Japan Human Plasma Protein Products Market Size (2018-2029)
1.3.6 South Korea Human Plasma Protein Products Market Size (2018-2029)
1.3.7 ASEAN Human Plasma Protein Products Market Size (2018-2029)
1.3.8 India Human Plasma Protein Products Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Plasma Protein Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Plasma Protein Products Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Plasma Protein Products Consumption Value (2018-2029)
2.2 World Human Plasma Protein Products Consumption Value by Region
2.2.1 World Human Plasma Protein Products Consumption Value by Region (2018-2023)
2.2.2 World Human Plasma Protein Products Consumption Value Forecast by Region (2024-2029)
2.3 United States Human Plasma Protein Products Consumption Value (2018-2029)
2.4 China Human Plasma Protein Products Consumption Value (2018-2029)
2.5 Europe Human Plasma Protein Products Consumption Value (2018-2029)
2.6 Japan Human Plasma Protein Products Consumption Value (2018-2029)
2.7 South Korea Human Plasma Protein Products Consumption Value (2018-2029)
2.8 ASEAN Human Plasma Protein Products Consumption Value (2018-2029)
2.9 India Human Plasma Protein Products Consumption Value (2018-2029)
3 WORLD HUMAN PLASMA PROTEIN PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Plasma Protein Products Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Plasma Protein Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Plasma Protein Products in 2022
3.2.3 Global Concentration Ratios (CR8) for Human Plasma Protein Products in 2022
3.3 Human Plasma Protein Products Company Evaluation Quadrant
3.4 Human Plasma Protein Products Market: Overall Company Footprint Analysis
3.4.1 Human Plasma Protein Products Market: Region Footprint
3.4.2 Human Plasma Protein Products Market: Company Product Type Footprint
3.4.3 Human Plasma Protein Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Plasma Protein Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Plasma Protein Products Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Human Plasma Protein Products Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Human Plasma Protein Products Consumption Value Comparison
4.2.1 United States VS China: Human Plasma Protein Products Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Plasma Protein Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Human Plasma Protein Products Companies and Market Share, 2018-2023
4.3.1 United States Based Human Plasma Protein Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Plasma Protein Products Revenue, (2018-2023)
4.4 China Based Companies Human Plasma Protein Products Revenue and Market Share, 2018-2023
4.4.1 China Based Human Plasma Protein Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Plasma Protein Products Revenue, (2018-2023)
4.5 Rest of World Based Human Plasma Protein Products Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Human Plasma Protein Products Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Plasma Protein Products Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Plasma Protein Products Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Globulin
5.2.2 Coagulation Factor
5.2.3 Albumin
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Human Plasma Protein Products Market Size by Type (2018-2023)
5.3.2 World Human Plasma Protein Products Market Size by Type (2024-2029)
5.3.3 World Human Plasma Protein Products Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Plasma Protein Products Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Human Plasma Protein Products Market Size by Application (2018-2023)
6.3.2 World Human Plasma Protein Products Market Size by Application (2024-2029)
6.3.3 World Human Plasma Protein Products Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Human Plasma Protein Products Product and Services
7.1.4 Takeda Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Human Plasma Protein Products Product and Services
7.2.4 CSL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 Grifols
7.3.1 Grifols Details
7.3.2 Grifols Major Business
7.3.3 Grifols Human Plasma Protein Products Product and Services
7.3.4 Grifols Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Grifols Recent Developments/Updates
7.3.6 Grifols Competitive Strengths & Weaknesses
7.4 Octapharma
7.4.1 Octapharma Details
7.4.2 Octapharma Major Business
7.4.3 Octapharma Human Plasma Protein Products Product and Services
7.4.4 Octapharma Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Octapharma Recent Developments/Updates
7.4.6 Octapharma Competitive Strengths & Weaknesses
7.5 Kedrion
7.5.1 Kedrion Details
7.5.2 Kedrion Major Business
7.5.3 Kedrion Human Plasma Protein Products Product and Services
7.5.4 Kedrion Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Kedrion Recent Developments/Updates
7.5.6 Kedrion Competitive Strengths & Weaknesses
7.6 LFB Group
7.6.1 LFB Group Details
7.6.2 LFB Group Major Business
7.6.3 LFB Group Human Plasma Protein Products Product and Services
7.6.4 LFB Group Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 LFB Group Recent Developments/Updates
7.6.6 LFB Group Competitive Strengths & Weaknesses
7.7 Biotest
7.7.1 Biotest Details
7.7.2 Biotest Major Business
7.7.3 Biotest Human Plasma Protein Products Product and Services
7.7.4 Biotest Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Biotest Recent Developments/Updates
7.7.6 Biotest Competitive Strengths & Weaknesses
7.8 BPL
7.8.1 BPL Details
7.8.2 BPL Major Business
7.8.3 BPL Human Plasma Protein Products Product and Services
7.8.4 BPL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 BPL Recent Developments/Updates
7.8.6 BPL Competitive Strengths & Weaknesses
7.9 RAAS
7.9.1 RAAS Details
7.9.2 RAAS Major Business
7.9.3 RAAS Human Plasma Protein Products Product and Services
7.9.4 RAAS Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 RAAS Recent Developments/Updates
7.9.6 RAAS Competitive Strengths & Weaknesses
7.10 CBPO
7.10.1 CBPO Details
7.10.2 CBPO Major Business
7.10.3 CBPO Human Plasma Protein Products Product and Services
7.10.4 CBPO Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CBPO Recent Developments/Updates
7.10.6 CBPO Competitive Strengths & Weaknesses
7.11 Hualan Bio
7.11.1 Hualan Bio Details
7.11.2 Hualan Bio Major Business
7.11.3 Hualan Bio Human Plasma Protein Products Product and Services
7.11.4 Hualan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hualan Bio Recent Developments/Updates
7.11.6 Hualan Bio Competitive Strengths & Weaknesses
7.12 Tiantan Bio
7.12.1 Tiantan Bio Details
7.12.2 Tiantan Bio Major Business
7.12.3 Tiantan Bio Human Plasma Protein Products Product and Services
7.12.4 Tiantan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Tiantan Bio Recent Developments/Updates
7.12.6 Tiantan Bio Competitive Strengths & Weaknesses
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Details
7.13.2 Shuanglin Bio Major Business
7.13.3 Shuanglin Bio Human Plasma Protein Products Product and Services
7.13.4 Shuanglin Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Shuanglin Bio Recent Developments/Updates
7.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
7.14 Boya Bio
7.14.1 Boya Bio Details
7.14.2 Boya Bio Major Business
7.14.3 Boya Bio Human Plasma Protein Products Product and Services
7.14.4 Boya Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Boya Bio Recent Developments/Updates
7.14.6 Boya Bio Competitive Strengths & Weaknesses
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Details
7.15.2 Yuanda Shuyang Major Business
7.15.3 Yuanda Shuyang Human Plasma Protein Products Product and Services
7.15.4 Yuanda Shuyang Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Yuanda Shuyang Recent Developments/Updates
7.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
7.16 Weiguang Bio
7.16.1 Weiguang Bio Details
7.16.2 Weiguang Bio Major Business
7.16.3 Weiguang Bio Human Plasma Protein Products Product and Services
7.16.4 Weiguang Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Weiguang Bio Recent Developments/Updates
7.16.6 Weiguang Bio Competitive Strengths & Weaknesses
7.17 Nanyue Bio
7.17.1 Nanyue Bio Details
7.17.2 Nanyue Bio Major Business
7.17.3 Nanyue Bio Human Plasma Protein Products Product and Services
7.17.4 Nanyue Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Nanyue Bio Recent Developments/Updates
7.17.6 Nanyue Bio Competitive Strengths & Weaknesses
7.18 KM Biologics
7.18.1 KM Biologics Details
7.18.2 KM Biologics Major Business
7.18.3 KM Biologics Human Plasma Protein Products Product and Services
7.18.4 KM Biologics Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 KM Biologics Recent Developments/Updates
7.18.6 KM Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Plasma Protein Products Industry Chain
8.2 Human Plasma Protein Products Upstream Analysis
8.3 Human Plasma Protein Products Midstream Analysis
8.4 Human Plasma Protein Products Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Plasma Protein Products Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Human Plasma Protein Products Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Human Plasma Protein Products Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Human Plasma Protein Products Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Human Plasma Protein Products Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Plasma Protein Products Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Human Plasma Protein Products Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Human Plasma Protein Products Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Human Plasma Protein Products Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Human Plasma Protein Products Players in 2022
Table 12. World Human Plasma Protein Products Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Human Plasma Protein Products Company Evaluation Quadrant
Table 14. Head Office of Key Human Plasma Protein Products Player
Table 15. Human Plasma Protein Products Market: Company Product Type Footprint
Table 16. Human Plasma Protein Products Market: Company Product Application Footprint
Table 17. Human Plasma Protein Products Mergers & Acquisitions Activity
Table 18. United States VS China Human Plasma Protein Products Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Human Plasma Protein Products Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Human Plasma Protein Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 23. China Based Human Plasma Protein Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 26. Rest of World Based Human Plasma Protein Products Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 29. World Human Plasma Protein Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Human Plasma Protein Products Market Size by Type (2018-2023) & (USD Million)
Table 31. World Human Plasma Protein Products Market Size by Type (2024-2029) & (USD Million)
Table 32. World Human Plasma Protein Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Human Plasma Protein Products Market Size by Application (2018-2023) & (USD Million)
Table 34. World Human Plasma Protein Products Market Size by Application (2024-2029) & (USD Million)
Table 35. Takeda Basic Information, Area Served and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Human Plasma Protein Products Product and Services
Table 38. Takeda Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Takeda Recent Developments/Updates
Table 40. Takeda Competitive Strengths & Weaknesses
Table 41. CSL Basic Information, Area Served and Competitors
Table 42. CSL Major Business
Table 43. CSL Human Plasma Protein Products Product and Services
Table 44. CSL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. CSL Recent Developments/Updates
Table 46. CSL Competitive Strengths & Weaknesses
Table 47. Grifols Basic Information, Area Served and Competitors
Table 48. Grifols Major Business
Table 49. Grifols Human Plasma Protein Products Product and Services
Table 50. Grifols Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Grifols Recent Developments/Updates
Table 52. Grifols Competitive Strengths & Weaknesses
Table 53. Octapharma Basic Information, Area Served and Competitors
Table 54. Octapharma Major Business
Table 55. Octapharma Human Plasma Protein Products Product and Services
Table 56. Octapharma Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Octapharma Recent Developments/Updates
Table 58. Octapharma Competitive Strengths & Weaknesses
Table 59. Kedrion Basic Information, Area Served and Competitors
Table 60. Kedrion Major Business
Table 61. Kedrion Human Plasma Protein Products Product and Services
Table 62. Kedrion Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Kedrion Recent Developments/Updates
Table 64. Kedrion Competitive Strengths & Weaknesses
Table 65. LFB Group Basic Information, Area Served and Competitors
Table 66. LFB Group Major Business
Table 67. LFB Group Human Plasma Protein Products Product and Services
Table 68. LFB Group Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. LFB Group Recent Developments/Updates
Table 70. LFB Group Competitive Strengths & Weaknesses
Table 71. Biotest Basic Information, Area Served and Competitors
Table 72. Biotest Major Business
Table 73. Biotest Human Plasma Protein Products Product and Services
Table 74. Biotest Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Biotest Recent Developments/Updates
Table 76. Biotest Competitive Strengths & Weaknesses
Table 77. BPL Basic Information, Area Served and Competitors
Table 78. BPL Major Business
Table 79. BPL Human Plasma Protein Products Product and Services
Table 80. BPL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. BPL Recent Developments/Updates
Table 82. BPL Competitive Strengths & Weaknesses
Table 83. RAAS Basic Information, Area Served and Competitors
Table 84. RAAS Major Business
Table 85. RAAS Human Plasma Protein Products Product and Services
Table 86. RAAS Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. RAAS Recent Developments/Updates
Table 88. RAAS Competitive Strengths & Weaknesses
Table 89. CBPO Basic Information, Area Served and Competitors
Table 90. CBPO Major Business
Table 91. CBPO Human Plasma Protein Products Product and Services
Table 92. CBPO Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CBPO Recent Developments/Updates
Table 94. CBPO Competitive Strengths & Weaknesses
Table 95. Hualan Bio Basic Information, Area Served and Competitors
Table 96. Hualan Bio Major Business
Table 97. Hualan Bio Human Plasma Protein Products Product and Services
Table 98. Hualan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Hualan Bio Competitive Strengths & Weaknesses
Table 101. Tiantan Bio Basic Information, Area Served and Competitors
Table 102. Tiantan Bio Major Business
Table 103. Tiantan Bio Human Plasma Protein Products Product and Services
Table 104. Tiantan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Tiantan Bio Recent Developments/Updates
Table 106. Tiantan Bio Competitive Strengths & Weaknesses
Table 107. Shuanglin Bio Basic Information, Area Served and Competitors
Table 108. Shuanglin Bio Major Business
Table 109. Shuanglin Bio Human Plasma Protein Products Product and Services
Table 110. Shuanglin Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Shuanglin Bio Recent Developments/Updates
Table 112. Shuanglin Bio Competitive Strengths & Weaknesses
Table 113. Boya Bio Basic Information, Area Served and Competitors
Table 114. Boya Bio Major Business
Table 115. Boya Bio Human Plasma Protein Products Product and Services
Table 116. Boya Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Boya Bio Recent Developments/Updates
Table 118. Boya Bio Competitive Strengths & Weaknesses
Table 119. Yuanda Shuyang Basic Information, Area Served and Competitors
Table 120. Yuanda Shuyang Major Business
Table 121. Yuanda Shuyang Human Plasma Protein Products Product and Services
Table 122. Yuanda Shuyang Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Yuanda Shuyang Recent Developments/Updates
Table 124. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 125. Weiguang Bio Basic Information, Area Served and Competitors
Table 126. Weiguang Bio Major Business
Table 127. Weiguang Bio Human Plasma Protein Products Product and Services
Table 128. Weiguang Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Weiguang Bio Recent Developments/Updates
Table 130. Weiguang Bio Competitive Strengths & Weaknesses
Table 131. Nanyue Bio Basic Information, Area Served and Competitors
Table 132. Nanyue Bio Major Business
Table 133. Nanyue Bio Human Plasma Protein Products Product and Services
Table 134. Nanyue Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Nanyue Bio Recent Developments/Updates
Table 136. KM Biologics Basic Information, Area Served and Competitors
Table 137. KM Biologics Major Business
Table 138. KM Biologics Human Plasma Protein Products Product and Services
Table 139. KM Biologics Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Human Plasma Protein Products Upstream (Raw Materials)
Table 141. Human Plasma Protein Products Typical Customers
LIST OF FIGURE
Figure 1. Human Plasma Protein Products Picture
Figure 2. World Human Plasma Protein Products Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Plasma Protein Products Total Market Size (2018-2029) & (USD Million)
Figure 4. World Human Plasma Protein Products Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Plasma Protein Products Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 13. Human Plasma Protein Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 16. World Human Plasma Protein Products Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 18. China Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 23. India Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Human Plasma Protein Products by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Plasma Protein Products Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Plasma Protein Products Markets in 2022
Figure 27. United States VS China: Human Plasma Protein Products Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Plasma Protein Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Human Plasma Protein Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Human Plasma Protein Products Market Size Market Share by Type in 2022
Figure 31. Immune Globulin
Figure 32. Coagulation Factor
Figure 33. Albumin
Figure 34. Other
Figure 35. World Human Plasma Protein Products Market Size Market Share by Type (2018-2029)
Figure 36. World Human Plasma Protein Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Human Plasma Protein Products Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Retail Pharmacy
Figure 40. Other
Figure 41. Human Plasma Protein Products Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Human Plasma Protein Products Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Human Plasma Protein Products Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Human Plasma Protein Products Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Human Plasma Protein Products Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Human Plasma Protein Products Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Plasma Protein Products Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Human Plasma Protein Products Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Human Plasma Protein Products Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Human Plasma Protein Products Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Human Plasma Protein Products Players in 2022
Table 12. World Human Plasma Protein Products Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Human Plasma Protein Products Company Evaluation Quadrant
Table 14. Head Office of Key Human Plasma Protein Products Player
Table 15. Human Plasma Protein Products Market: Company Product Type Footprint
Table 16. Human Plasma Protein Products Market: Company Product Application Footprint
Table 17. Human Plasma Protein Products Mergers & Acquisitions Activity
Table 18. United States VS China Human Plasma Protein Products Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Human Plasma Protein Products Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Human Plasma Protein Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 23. China Based Human Plasma Protein Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 26. Rest of World Based Human Plasma Protein Products Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Plasma Protein Products Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Human Plasma Protein Products Revenue Market Share (2018-2023)
Table 29. World Human Plasma Protein Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Human Plasma Protein Products Market Size by Type (2018-2023) & (USD Million)
Table 31. World Human Plasma Protein Products Market Size by Type (2024-2029) & (USD Million)
Table 32. World Human Plasma Protein Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Human Plasma Protein Products Market Size by Application (2018-2023) & (USD Million)
Table 34. World Human Plasma Protein Products Market Size by Application (2024-2029) & (USD Million)
Table 35. Takeda Basic Information, Area Served and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Human Plasma Protein Products Product and Services
Table 38. Takeda Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Takeda Recent Developments/Updates
Table 40. Takeda Competitive Strengths & Weaknesses
Table 41. CSL Basic Information, Area Served and Competitors
Table 42. CSL Major Business
Table 43. CSL Human Plasma Protein Products Product and Services
Table 44. CSL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. CSL Recent Developments/Updates
Table 46. CSL Competitive Strengths & Weaknesses
Table 47. Grifols Basic Information, Area Served and Competitors
Table 48. Grifols Major Business
Table 49. Grifols Human Plasma Protein Products Product and Services
Table 50. Grifols Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Grifols Recent Developments/Updates
Table 52. Grifols Competitive Strengths & Weaknesses
Table 53. Octapharma Basic Information, Area Served and Competitors
Table 54. Octapharma Major Business
Table 55. Octapharma Human Plasma Protein Products Product and Services
Table 56. Octapharma Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Octapharma Recent Developments/Updates
Table 58. Octapharma Competitive Strengths & Weaknesses
Table 59. Kedrion Basic Information, Area Served and Competitors
Table 60. Kedrion Major Business
Table 61. Kedrion Human Plasma Protein Products Product and Services
Table 62. Kedrion Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Kedrion Recent Developments/Updates
Table 64. Kedrion Competitive Strengths & Weaknesses
Table 65. LFB Group Basic Information, Area Served and Competitors
Table 66. LFB Group Major Business
Table 67. LFB Group Human Plasma Protein Products Product and Services
Table 68. LFB Group Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. LFB Group Recent Developments/Updates
Table 70. LFB Group Competitive Strengths & Weaknesses
Table 71. Biotest Basic Information, Area Served and Competitors
Table 72. Biotest Major Business
Table 73. Biotest Human Plasma Protein Products Product and Services
Table 74. Biotest Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Biotest Recent Developments/Updates
Table 76. Biotest Competitive Strengths & Weaknesses
Table 77. BPL Basic Information, Area Served and Competitors
Table 78. BPL Major Business
Table 79. BPL Human Plasma Protein Products Product and Services
Table 80. BPL Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. BPL Recent Developments/Updates
Table 82. BPL Competitive Strengths & Weaknesses
Table 83. RAAS Basic Information, Area Served and Competitors
Table 84. RAAS Major Business
Table 85. RAAS Human Plasma Protein Products Product and Services
Table 86. RAAS Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. RAAS Recent Developments/Updates
Table 88. RAAS Competitive Strengths & Weaknesses
Table 89. CBPO Basic Information, Area Served and Competitors
Table 90. CBPO Major Business
Table 91. CBPO Human Plasma Protein Products Product and Services
Table 92. CBPO Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CBPO Recent Developments/Updates
Table 94. CBPO Competitive Strengths & Weaknesses
Table 95. Hualan Bio Basic Information, Area Served and Competitors
Table 96. Hualan Bio Major Business
Table 97. Hualan Bio Human Plasma Protein Products Product and Services
Table 98. Hualan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Hualan Bio Competitive Strengths & Weaknesses
Table 101. Tiantan Bio Basic Information, Area Served and Competitors
Table 102. Tiantan Bio Major Business
Table 103. Tiantan Bio Human Plasma Protein Products Product and Services
Table 104. Tiantan Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Tiantan Bio Recent Developments/Updates
Table 106. Tiantan Bio Competitive Strengths & Weaknesses
Table 107. Shuanglin Bio Basic Information, Area Served and Competitors
Table 108. Shuanglin Bio Major Business
Table 109. Shuanglin Bio Human Plasma Protein Products Product and Services
Table 110. Shuanglin Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Shuanglin Bio Recent Developments/Updates
Table 112. Shuanglin Bio Competitive Strengths & Weaknesses
Table 113. Boya Bio Basic Information, Area Served and Competitors
Table 114. Boya Bio Major Business
Table 115. Boya Bio Human Plasma Protein Products Product and Services
Table 116. Boya Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Boya Bio Recent Developments/Updates
Table 118. Boya Bio Competitive Strengths & Weaknesses
Table 119. Yuanda Shuyang Basic Information, Area Served and Competitors
Table 120. Yuanda Shuyang Major Business
Table 121. Yuanda Shuyang Human Plasma Protein Products Product and Services
Table 122. Yuanda Shuyang Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Yuanda Shuyang Recent Developments/Updates
Table 124. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 125. Weiguang Bio Basic Information, Area Served and Competitors
Table 126. Weiguang Bio Major Business
Table 127. Weiguang Bio Human Plasma Protein Products Product and Services
Table 128. Weiguang Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Weiguang Bio Recent Developments/Updates
Table 130. Weiguang Bio Competitive Strengths & Weaknesses
Table 131. Nanyue Bio Basic Information, Area Served and Competitors
Table 132. Nanyue Bio Major Business
Table 133. Nanyue Bio Human Plasma Protein Products Product and Services
Table 134. Nanyue Bio Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Nanyue Bio Recent Developments/Updates
Table 136. KM Biologics Basic Information, Area Served and Competitors
Table 137. KM Biologics Major Business
Table 138. KM Biologics Human Plasma Protein Products Product and Services
Table 139. KM Biologics Human Plasma Protein Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Human Plasma Protein Products Upstream (Raw Materials)
Table 141. Human Plasma Protein Products Typical Customers
LIST OF FIGURE
Figure 1. Human Plasma Protein Products Picture
Figure 2. World Human Plasma Protein Products Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Plasma Protein Products Total Market Size (2018-2029) & (USD Million)
Figure 4. World Human Plasma Protein Products Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Plasma Protein Products Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Human Plasma Protein Products Revenue (2018-2029) & (USD Million)
Figure 13. Human Plasma Protein Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 16. World Human Plasma Protein Products Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 18. China Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 23. India Human Plasma Protein Products Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Human Plasma Protein Products by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Plasma Protein Products Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Plasma Protein Products Markets in 2022
Figure 27. United States VS China: Human Plasma Protein Products Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Plasma Protein Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Human Plasma Protein Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Human Plasma Protein Products Market Size Market Share by Type in 2022
Figure 31. Immune Globulin
Figure 32. Coagulation Factor
Figure 33. Albumin
Figure 34. Other
Figure 35. World Human Plasma Protein Products Market Size Market Share by Type (2018-2029)
Figure 36. World Human Plasma Protein Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Human Plasma Protein Products Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Retail Pharmacy
Figure 40. Other
Figure 41. Human Plasma Protein Products Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
